(Q42439006)

English

15-prostaglandin dehydrogenase expression alone or in combination with ACSM1 defines a subgroup of the apocrine molecular subtype of breast carcinoma.

scientific article published on 16 July 2008

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

31 October 2017

15-prostaglandin dehydrogenase expression alone or in combination with ACSM1 defines a subgroup of the apocrine molecular subtype of breast carcinoma. (English)

1 reference

Europe PubMed Central

PubMed publication ID

31 October 2017

Antonio Llombart-Bosch

7

object named as

Antonio Llombart-Bosch

0 references

Karin Jirström

6

object named as

Karin Jirström

1 reference

Europe PubMed Central

PubMed publication ID

31 October 2017

author name string

Julio E Celis

1

1 reference

Europe PubMed Central

PubMed publication ID

31 October 2017

Pavel Gromov

2

1 reference

Europe PubMed Central

PubMed publication ID

31 October 2017

Teresa Cabezón

3

1 reference

Europe PubMed Central

PubMed publication ID

31 October 2017

José M A Moreira

4

1 reference

Europe PubMed Central

PubMed publication ID

31 October 2017

Esbern Friis

5

1 reference

Europe PubMed Central

PubMed publication ID

31 October 2017

Antonio Llombart-Bosch

7

1 reference

Europe PubMed Central

PubMed publication ID

31 October 2017

Vera Timmermans-Wielenga

8

1 reference

Europe PubMed Central

PubMed publication ID

31 October 2017

Fritz Rank

9

1 reference

Europe PubMed Central

PubMed publication ID

31 October 2017

Irina Gromova

10

1 reference

Europe PubMed Central

PubMed publication ID

31 October 2017

publication date

16 July 2008

1 reference

Europe PubMed Central

PubMed publication ID

31 October 2017

Molecular & Cellular Proteomics

1 reference

Europe PubMed Central

PubMed publication ID

31 October 2017

7

1 reference

Europe PubMed Central

PubMed publication ID

31 October 2017

10

1 reference

Europe PubMed Central

PubMed publication ID

31 October 2017

1795-1809

1 reference

Europe PubMed Central

PubMed publication ID

31 October 2017

Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R800011-MCP200

21 January 2018

Recent trends in cancer survival across Europe between 2000 and 2004: a model-based period analysis from 12 cancer registries

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R800011-MCP200

21 January 2018

Molecular portraits of human breast tumours

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R800011-MCP200

21 January 2018

Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R800011-MCP200

21 January 2018

Identification of molecular apocrine breast tumours by microarray analysis.

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R800011-MCP200

21 January 2018

Non-operative breast pathology: apocrine lesions

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R800011-MCP200

21 January 2018

Invasive apocrine carcinoma of the breast: clinicopathologic features of 57 patients

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R800011-MCP200

21 January 2018

Apocrine mammary carcinoma. A clinicopathologic study of 72 cases

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R800011-MCP200

21 January 2018

Apocrine cysts of the breast: biomarkers, origin, enlargement, and relation with cancer phenotype.

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R800011-MCP200

21 January 2018

Molecular pathology of breast apocrine carcinomas: a protein expression signature specific for benign apocrine metaplasia.

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R800011-MCP200

21 January 2018

Immunohistochemical analysis of apocrine breast lesions. Consistent over-expression of androgen receptor accompanied by the loss of estrogen and progesterone receptors in apocrine metaplasia and apocrine carcinoma in situ.

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R800011-MCP200

21 January 2018

Immunohistochemical localisation of androgen receptor in apocrine metaplasia and apocrine adenosis of the breast: relation to oestrogen and progesterone receptors

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R800011-MCP200

21 January 2018

Hormone receptor profile of apocrine lesions of the breast.

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R800011-MCP200

21 January 2018

Androgen receptors frequently are expressed in breast carcinomas: potential relevance to new therapeutic strategies.

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R800011-MCP200

21 January 2018

Expression of GCDFP-15 and AR decreases in larger or node-positive apocrine carcinomas of the breast

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R800011-MCP200

21 January 2018

Loss of heterozygosity in fibrocystic change of the breast: genetic relationship between benign proliferative lesions and associated carcinomas

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R800011-MCP200

21 January 2018

High-resolution chromosome 3p allelotyping of breast carcinomas and precursor lesions demonstrates frequent loss of heterozygosity and a discontinuous pattern of allele loss

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R800011-MCP200

21 January 2018

Molecular cytogenetic comparison of apocrine hyperplasia and apocrine carcinoma of the breast

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R800011-MCP200

21 January 2018

Characterization of breast precancerous lesions and myoepithelial hyperplasia in sclerosing adenosis with apocrine metaplasia

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R800011-MCP200

21 January 2018

Oestrogen receptors alpha and beta show different associations to clinicopathological parameters and their co-expression might predict a better response to endocrine treatment in breast cancer

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R800011-MCP200

21 January 2018

Identification of a subset of breast carcinomas characterized by expression of cytokeratin 15: relationship between CK15+ progenitor/amplified cells and pre-malignant lesions and invasive disease.

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R800011-MCP200

21 January 2018

Mass Spectrometric Sequencing of Proteins from Silver-Stained Polyacrylamide Gels

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R800011-MCP200

21 January 2018

Proteomic characterization of the interstitial fluid perfusing the breast tumor microenvironment: a novel resource for biomarker and therapeutic target discovery

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R800011-MCP200

21 January 2018

Down-regulation of the tumor suppressor protein 14-3-3sigma is a sporadic event in cancer of the breast.

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R800011-MCP200

21 January 2018

Breast macrocysts

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R800011-MCP200

21 January 2018

Apocrine ductal carcinoma in situ of the breast: histologic classification and expression of biologic markers

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R800011-MCP200

21 January 2018

GATA-3 maintains the differentiation of the luminal cell fate in the mammary gland

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R800011-MCP200

21 January 2018

Gata-3 is an essential regulator of mammary-gland morphogenesis and luminal-cell differentiation

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R800011-MCP200

21 January 2018

Repeated observation of breast tumor subtypes in independent gene expression data sets

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R800011-MCP200

21 January 2018

Statins and their roles in cancer

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R800011-MCP200

21 January 2018

Prostaglandins and cancer

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R800011-MCP200

21 January 2018

Palpable right breast mass in a pregnant woman.

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R800011-MCP200

21 January 2018

Advances in the biology of lung cancer chemoprevention

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R800011-MCP200

21 January 2018

15-hydroxyprostaglandin dehydrogenase is a tumor suppressor of human breast cancer

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R800011-MCP200

21 January 2018

Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R800011-MCP200

21 January 2018

Correlation between immunohistochemistry (HercepTest) and fluorescence in situ hybridization (FISH) for HER-2 in 426 breast carcinomas from 37 centres.

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R800011-MCP200

21 January 2018

Identifiers

10.1074/MCP.R800011-MCP200

1 reference

Europe PubMed Central

PubMed publication ID

31 October 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

31 October 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42439006&oldid=1572102605"